Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_assertion type Assertion NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_head.
- NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_assertion description "[Inactivating HRPT2 mutations are common in HPT- JT and parathyroid carcinomas, and have been described in a few cases of parathyroid adenomas with cystic features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_provenance.
- NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_assertion evidence source_evidence_literature NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_provenance.
- NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_assertion SIO_000772 16728578 NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_provenance.
- NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_assertion wasDerivedFrom befree-20140225 NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_provenance.
- NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_assertion wasGeneratedBy ECO_0000203 NP208338.RA8Xe3wHz4Jdh8t9ZRZ-frzRWIDXWEUcwB9zTcJjOLZNs130_provenance.